Section Editors: Sapna Rawal,1 Matylda Machnowska,1 Anvita Pauranik2
1University of Toronto, Toronto, Ontario, Canada
2University of Calgary, Calgary, Alberta, Canada
A 27-year-old woman with promyelocytic leukemia presenting with headache and diplopia after all-trans retinoic acid (ATRA) therapy (top row). Follow-up 20 days later after discontinuation of ATRA, lumbar puncture, and acetazolamide therapy, with complete remission of symptoms (bottom row).
Gianfranco Vornetti, Luca Spinardi, Luca Faccioli, Marco Pastore Trossello
Neuroradiology Unit, Sant’Orsola-Malpighi Hospital, Bologna, Italy